|
|
tissue remodeling
|
GO:0048771 |
102 |
0.334
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.244
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.214
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.208
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.180
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.157
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.157
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.146
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.145
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.144
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.113
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.110
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.105
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.105
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.103
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.102
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.099
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.096
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.093
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.093
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.088
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.082
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.082
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.079
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.078
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.078
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.076
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.075
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.074
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.074
|
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.073
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.073
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.072
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.072
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.071
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.071
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.071
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.070
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.064
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.063
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.062
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.062
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.062
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.062
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.061
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.060
|
Mouse |
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.059
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.058
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.058
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.058
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.058
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.058
|
Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.056
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.056
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.055
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.055
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.055
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.054
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.054
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.054
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.053
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.053
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.053
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.052
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.052
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.051
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.050
|
Mouse |
|
|
heart process
|
GO:0003015 |
94 |
0.049
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.048
|
|
|
|
metanephric distal convoluted tubule development
|
GO:0072221 |
5 |
0.047
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.047
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.046
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.045
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.045
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.045
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.044
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.044
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.043
|
Mouse |
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.043
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.042
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.042
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.042
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.042
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.041
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.041
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.041
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.041
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.040
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.040
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.039
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.039
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.039
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.039
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.038
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.038
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.038
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.037
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.037
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.036
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.036
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.036
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.036
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.036
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.035
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.035
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.035
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.035
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.035
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.035
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.035
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.034
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.034
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.034
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.034
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.034
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.034
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.034
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.034
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.034
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.033
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.033
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.033
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
3 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.033
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.032
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.032
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.032
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.032
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.031
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.031
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.031
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.031
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.031
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.031
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.030
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.030
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.030
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.029
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.029
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.029
|
Mouse |
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.028
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.028
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.028
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.028
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.028
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.027
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.027
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.027
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.027
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.027
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.026
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.026
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.025
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.025
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.025
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.025
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.025
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.024
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.024
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.024
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.024
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.024
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.024
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.024
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.024
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.024
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
Mouse |
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.023
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.023
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.023
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.023
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.023
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.023
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.023
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.023
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.022
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.022
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.022
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.022
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.022
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.022
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
Mouse |
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.022
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.022
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.021
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.021
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.021
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.021
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.021
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.021
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.021
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.021
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.021
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.020
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.020
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.020
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.020
|
|
|
|
negative t cell selection
|
GO:0043383 |
13 |
0.020
|
|
|
|
dopamine transport
|
GO:0015872 |
15 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.020
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.020
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.020
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.020
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.020
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.020
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.020
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.019
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.019
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.019
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.019
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.019
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.019
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.019
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.019
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.019
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.019
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.019
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.019
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.019
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.019
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.018
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.018
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.018
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.018
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.018
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.018
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.018
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.018
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.018
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.018
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.018
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.017
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.017
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.017
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.017
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.017
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.017
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.017
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.017
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.017
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.017
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.017
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.017
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
12 |
0.017
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.017
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.017
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.017
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.017
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.017
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.017
|
|
|
|
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001988 |
1 |
0.016
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.016
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.016
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.016
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.016
|
|
|
|
negative regulation of cyclase activity
|
GO:0031280 |
1 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.016
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.016
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.016
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.016
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.016
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.016
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.016
|
|
|
|
regulation of dopamine secretion
|
GO:0014059 |
9 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.015
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.015
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.015
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.015
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.015
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.015
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.015
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.015
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.015
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.015
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.015
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.015
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.015
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.015
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.015
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.015
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.014
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.014
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.014
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.014
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.014
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.014
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.014
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.014
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.014
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.014
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.014
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.014
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.014
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.014
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.014
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.014
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.014
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.014
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.014
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.014
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.014
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.014
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.014
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.014
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.014
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.014
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.014
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.014
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.014
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.014
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.014
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.014
|
|
|
|
negative thymic t cell selection
|
GO:0045060 |
12 |
0.014
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.014
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.013
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.013
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.013
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.013
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.013
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.013
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.013
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.013
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.013
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.013
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.013
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.013
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.013
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.013
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.013
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.013
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.013
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.013
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.013
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.013
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.013
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.013
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.013
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.013
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.013
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.013
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.013
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.013
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.013
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.013
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.013
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.013
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.013
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.012
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.012
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.012
|
|
|
|
lateral geniculate nucleus development
|
GO:0021771 |
1 |
0.012
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.012
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.012
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.012
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.012
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.012
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.012
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.012
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.012
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.012
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.012
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
